The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections
Intensive Care Medicine · 2024-06 · 50 (6) · 873-889
DOI: 10.1007/s00134-024-07348-0 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Intensive Care Medicine, online erschienen am 18.03.2024. Verfasst von Niccolò Buetti und 20 weiteren Autor:innen. Beteiligte Einrichtung: Infection Control Program, Geneva University Hospitals and Faculty of Medicine, World Health Organization Collaborating Centre, Geneva, Switzerland. …. Hauptthemen laut MEDLINE: Cross Infection, Critical Illness, Intensive Care Units. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council, European Society of Intensive Care Medicine, European Society of Clinical Microbiology and Infectious Diseases.
Abstract (Originalsprache)
PURPOSE: The primary objective of this study was to evaluate the associations between centre/country-based factors and two important process and outcome indicators in patients with hospital-acquired bloodstream infections (HABSI). METHODS: We used data on HABSI from the prospective EUROBACT-2 study to evaluate the associations between centre/country factors on a process or an outcome indicator: adequacy of antimicrobial therapy within the first 24 h or 28-day mortality, respectively. Mixed logistical models with clustering by centre identified factors associated with both indicators. RESULTS: Two thousand two hundred nine patients from two hundred one intensive care units (ICUs) were included in forty-seven countries. Overall, 51% (n = 1128) of patients received an adequate antimicrobial therapy and the 28-day mortality was 38% (n = 839). The availability of therapeutic drug monitoring (TDM) for aminoglycosides everyday [odds ratio (OR) 1.48, 95% confidence interval (CI) 1.03-2.14] or within a few hours (OR 1.79, 95% CI 1.34-2.38), surveillance cultures for multidrug-resistant organism carriage performed weekly (OR 1.45, 95% CI 1.09-1.93), and increasing Human Development Index (HDI) values were associated with adequate antimicrobial therapy. The presence of intermediate care beds (OR 0.63, 95% CI 0.47-0.84), TDM for aminoglycoside available everyday (OR 0.66, 95% CI 0.44-1.00) or within a few hours (OR 0.51, 95% CI 0.37-0.70), 24/7 consultation of clinical pharmacists (OR 0.67, 95% CI 0.47-0.95), percentage of vancomycin-resistant enterococci (VRE) between 10% and 25% in the ICU (OR 1.67, 95% CI 1.00-2.80), and decreasing HDI values were associated with 28-day mortality. CONCLUSION: Centre/country factors should be targeted for future interventions to improve management strategies and outcome of HABSI in ICU patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infection Control Program, Geneva University Hospitals and Faculty of Medicine, World Health Organization Collaborating Centre, Geneva, Switzerland. niccolo.buetti@gmail.com.
- IAME UMR 1137, INSERM, Université Paris-Cité, Paris, France. niccolo.buetti@gmail.com.
- Intensive Care Unit, Redcliffe Hospital, Brisbane, Australia.
- Queensland Critical Care Research Network (QCCRN), Brisbane, QLD, Australia.
- Queensland University of Technology, Brisbane, QLD, Australia.
- Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
ORCID-Profile: Niccolò Buetti, Jean-François Timsit
Förderung
- Medical Research Council
- European Society of Intensive Care Medicine
- European Society of Clinical Microbiology and Infectious Diseases
- Norva Dahlia foundation and the Redcliffe Hospital Private Practice Trust Fund
- University of Geneva
Zitieren
APA
Buetti, N., Tabah, A., Setti, N., Ruckly, S., Barbier, F., Akova, M., Aslan, A. T., Leone, M., Bassetti, M., Morris, A. C., Arvaniti, K., Paiva, J. A., Ferrer, R., Qiu, H., Montrucchio, G., Cortegiani, A., Kayaaslan, B., De Bus, L., De Waele, J. J., …, & EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID… (2024). The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections. Intensive Care Medicine, 50(6), 873-889. https://doi.org/10.1007/s00134-024-07348-0
Vancouver
Buetti N, Tabah A, Setti N, Ruckly S, Barbier F, Akova M, et al. The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections. Intensive Care Medicine. 2024;50(6):873-889. doi:10.1007/s00134-024-07348-0
BibTeX
@article{Buetti2024,
author = {Buetti, Niccolò and Tabah, Alexis and Setti, Nour and Ruckly, Stéphane and Barbier, François and Akova, Murat and Aslan, Abdullah Tarik and Leone, Marc and Bassetti, Matteo and Morris, Andrew Conway and Arvaniti, Kostoula and Paiva, José-Artur and Ferrer, Ricard and Qiu, Haibo and Montrucchio, Giorgia and Cortegiani, Andrea and Kayaaslan, Bircan and De Bus, Liesbet and De Waele, Jan J and Timsit, Jean-François and EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID…, EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID…},
title = {The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections},
journal = {Intensive Care Medicine},
year = {2024},
volume = {50},
number = {6},
pages = {873--889},
doi = {10.1007/s00134-024-07348-0}
}
EUVIMED